Shares of MINDBODY Inc (NASDAQ:MB) have received an average rating of “Hold” from the seventeen analysts that are currently covering the company, Marketbeat.com reports. Ten equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $33.70.
A number of research analysts have issued reports on MB shares. William Blair started coverage on shares of MINDBODY in a research report on Wednesday, September 26th. They set a “market perform” rating on the stock. Wells Fargo & Co started coverage on shares of MINDBODY in a research report on Friday, September 7th. They set an “outperform” rating and a $45.00 target price on the stock. JPMorgan Chase & Co. downgraded shares of MINDBODY from an “overweight” rating to a “neutral” rating and cut their target price for the company from $48.00 to $31.00 in a research report on Wednesday. Credit Suisse Group cut their target price on shares of MINDBODY from $41.00 to $38.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 1st. Finally, ValuEngine downgraded shares of MINDBODY from a “buy” rating to a “hold” rating in a research report on Wednesday.
In other news, Director Adam L. Miller purchased 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 14th. The shares were acquired at an average cost of $35.66 per share, for a total transaction of $106,980.00. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Luxor Capital Group, Lp purchased 144,100 shares of the business’s stock in a transaction that occurred on Friday, November 2nd. The stock was purchased at an average price of $33.51 per share, for a total transaction of $4,828,791.00. The disclosure for this purchase can be found here. Insiders sold a total of 127,809 shares of company stock worth $4,430,896 over the last quarter. 6.02% of the stock is currently owned by corporate insiders.
Several large investors have recently made changes to their positions in MB. Nelson Roberts Investment Advisors LLC increased its stake in MINDBODY by 1.1% during the 2nd quarter. Nelson Roberts Investment Advisors LLC now owns 123,901 shares of the technology company’s stock worth $4,783,000 after purchasing an additional 1,325 shares in the last quarter. Rhumbline Advisers increased its stake in MINDBODY by 4.4% during the 2nd quarter. Rhumbline Advisers now owns 41,030 shares of the technology company’s stock worth $1,584,000 after purchasing an additional 1,737 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in MINDBODY by 6.0% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 31,443 shares of the technology company’s stock worth $1,278,000 after purchasing an additional 1,774 shares in the last quarter. JPMorgan Chase & Co. increased its stake in MINDBODY by 13.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 15,345 shares of the technology company’s stock worth $624,000 after purchasing an additional 1,872 shares in the last quarter. Finally, Arthur M. Cohen & Associates LLC increased its stake in MINDBODY by 27.8% during the 2nd quarter. Arthur M. Cohen & Associates LLC now owns 11,500 shares of the technology company’s stock worth $444,000 after purchasing an additional 2,500 shares in the last quarter. Institutional investors and hedge funds own 98.86% of the company’s stock.
NASDAQ MB traded down $0.18 on Monday, hitting $26.82. 1,246,871 shares of the company were exchanged, compared to its average volume of 1,253,458. The company has a current ratio of 9.61, a quick ratio of 9.61 and a debt-to-equity ratio of 0.86. MINDBODY has a 1-year low of $24.75 and a 1-year high of $45.50.
MINDBODY (NASDAQ:MB) last issued its quarterly earnings results on Tuesday, November 6th. The technology company reported ($0.05) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. The business had revenue of $63.80 million for the quarter, compared to the consensus estimate of $63.99 million. MINDBODY had a negative net margin of 16.91% and a negative return on equity of 9.26%. The firm’s quarterly revenue was up 36.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.01 EPS. Research analysts expect that MINDBODY will post -0.64 EPS for the current fiscal year.
MINDBODY, Inc operates a cloud-based business management software and payments platform for the small and medium-sized businesses in the wellness services industry. Its platform enables businesses to run, market, and build scheduling and online booking, performance tracking, staff management, client relationship management, integrated payment processing, retail point-of-sale, purchase tracking, inventory, hardware integration, analytics and reporting, branded Web, mobility, social integration, client acquisition dashboard, security and compliance, and integration with other cloud-based partners for yoga, Pilates, indoor cycling, group and personal training, boutique fitness, salons, spas, and integrative health businesses.
Read More: 52-Week High/Low
Receive News & Ratings for MINDBODY Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY and related companies with MarketBeat.com's FREE daily email newsletter.